These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 25791243)

  • 1. Remissions of different quality following rituximab, tocilizumab and rituximab, and allogeneic stem cell transplantation in a patient with severe idiopathic multicentric Castleman's disease.
    Angenendt L; Kerkhoff A; Wiebe S; Mikesch JH; Rudat A; Wötzel F; Wenning C; Schliemann C; Kessler T; Schäfers M; Wardelmann E; Stelljes M; Berdel WE
    Ann Hematol; 2015 Jul; 94(7):1241-3. PubMed ID: 25791243
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term remission in idiopathic Castleman's disease with tocilizumab followed by consolidation with high-dose melphalan--two case studies.
    Jerkeman M; Lindén O
    Eur J Haematol; 2016 May; 96(5):541-3. PubMed ID: 26256458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful tocilizumab treatment in a patient with human herpesvirus 8-positive and human immunodeficiency virus-negative multicentric Castleman's disease of plasma cell type nonresponsive to rituximab-CVP therapy.
    Műzes G; Sipos F; Csomor J; Sréter L
    APMIS; 2013 Jul; 121(7):668-74. PubMed ID: 23163599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful use of tocilizumab in a case of multicentric Castleman's disease and end-stage renal disease.
    Nagai K; Ueda A; Yamagata K
    Ther Apher Dial; 2014 Apr; 18(2):210-1. PubMed ID: 24571441
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thoracic manifestations of Castleman's disease].
    Dégot T; Métivier A-; Casnedi S; Chenard M-; Kessler R
    Rev Pneumol Clin; 2009 Apr; 65(2):101-7. PubMed ID: 19375050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete remission with anti-CD20 therapy for unicentric, non-HIV-associated, hyaline-vascular type, Castleman's disease.
    Estephan FF; Elghetany MT; Berry M; Jones DV
    Cancer Invest; 2005; 23(2):191. PubMed ID: 15813512
    [No Abstract]   [Full Text] [Related]  

  • 7. Evan's syndrome complicating multicentric Castleman's disease -- dramatic response to rituximab.
    Quinn JP; Gilligan OM; Horgan M
    Eur J Haematol; 2004 Nov; 73(5):384-5. PubMed ID: 15458520
    [No Abstract]   [Full Text] [Related]  

  • 8. [Castleman's disease, HIV and rituximab].
    Valencia ME; López V; Corcuera MT; Del Val D
    Rev Clin Esp; 2012 Feb; 212(2):118-9. PubMed ID: 21924712
    [No Abstract]   [Full Text] [Related]  

  • 9. Multicentric Castleman's disease & HIV infection.
    Cotter A; Lambert J; O'Gorman P
    Ir Med J; 2009 Oct; 102(9):294-5. PubMed ID: 19902650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of rituximab for TAFRO syndrome, a variant type of multicentric Castleman's disease].
    Ozawa T; Kosugi S; Kito M; Onishi M; Kida T; Nakata S; Take H; Katagiri S
    Rinsho Ketsueki; 2014 Mar; 55(3):350-5. PubMed ID: 24681940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of long term administration of humanized anti-interleukin-6 receptor antibody (tocilizumab) for multicentric Castleman's disease with pulmonary involvement].
    Akahane D; Kimura Y; Sumi M; Sashida G; Gotoh A; Miyazawa K; Ohyashiki K
    Rinsho Ketsueki; 2006 Aug; 47(8):748-52. PubMed ID: 16986713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Durable remission with rituximab in a patient with an unusual variant of Castleman's disease with myelofibrosis-TAFRO syndrome.
    Jain P; Verstovsek S; Loghavi S; Jorgensen JL; Patel KP; Estrov Z; Fayad L; Pemmaraju N
    Am J Hematol; 2015 Nov; 90(11):1091-2. PubMed ID: 25808231
    [No Abstract]   [Full Text] [Related]  

  • 13. Complete remission in 4 patients with human herpesvirus 8-associated multicentric Castleman disease using rituximab and liposomal doxorubicin, a novel chemotherapy combination.
    Peker D; Martinez AE; Schwartz MA; Cusnir M
    Clin Adv Hematol Oncol; 2012 Mar; 10(3):204-6. PubMed ID: 22402431
    [No Abstract]   [Full Text] [Related]  

  • 14. [Castleman's disease: Rapid desensitization for hypersensitivity reaction to rituximab].
    Boin C; Lambert S; Thomann P; Aujoulat O; Kieffer P
    Rev Med Interne; 2016 Jun; 37(6):433-6. PubMed ID: 26415921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vinblastine, rituximab and HAART, treatment of an HIV -positive patient with multicentric Castleman's disease.
    van Aalderen MC; Brinkman K; van den Berk GE; Terpstra WE
    Neth J Med; 2010 Feb; 68(2):87-90. PubMed ID: 20167961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term remission in HIV-negative patients with multicentric Castleman's disease using rituximab.
    Ide M; Kawachi Y; Izumi Y; Kasagi K; Ogino T
    Eur J Haematol; 2006 Feb; 76(2):119-23. PubMed ID: 16405432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of aggressive HIV-associated multicentric Castleman's disease: a case report.
    Flejsierowicz M; Ahmed MS; Kotov P; Cheng YC
    WMJ; 2008 Jul; 107(4):191-4. PubMed ID: 18702436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Localized and multicentric Castleman's disease: two different clinical and evolutive forms].
    Ines ZI; Belcadhi M; Belakhdher M; Bouslama M; Mani R; Ben Ali M; Abdelkefi M; El Omri H; Sriha B; Bouzouita K
    Tunis Med; 2008 Nov; 86(11):1025-7. PubMed ID: 19213506
    [No Abstract]   [Full Text] [Related]  

  • 19. Fulminant HHV-8 associated Castleman's disease in a non-HIV, Kaposi sarcoma patient with borderline hemophagocytic syndrome.
    Barbarov I; Koren-Michowitz M; Schiby G; Portnoy O; Livingstone D; Segal G
    Isr Med Assoc J; 2015 Apr; 17(4):253-5. PubMed ID: 26040056
    [No Abstract]   [Full Text] [Related]  

  • 20. [Multicentric Castleman's disease found by a renal sinus lesion: a case report].
    Nagahama K; Higashi K; Sanada S; Nezumi M; Itou H
    Hinyokika Kiyo; 2000 Feb; 46(2):95-9. PubMed ID: 10769797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.